All In MedTech

FDA Clearance Tracker · P930014-S066

ACRYSOF INTRAOCULAR LENSES (IOLS)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 23, 2013 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 23, 2013

Approved

Time to decision

209 days

Received Dec 26, 2012. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P930014-S066
Device name
ACRYSOF INTRAOCULAR LENSES (IOLS)
Applicant location
Fort Worth, TX
Received
Dec 26, 2012
Decided
Jul 23, 2013
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P930014

Device type

Device class
Class III
Regulation
21 CFR 886.3600
Specialty
Ophthalmology

Every decision under product code HQL

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A MANUFACTURING SITE LOCATED AT ALCON RESEARCH, LTD., IN LESAGE, WEST VIRGINIA.

Source documents

Other decisions for Alcon Laboratories, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.